Cargando…
TP63 isoform expression is linked with distinct clinical outcomes in cancer
BACKGROUND: Half of muscle-invasive bladder cancer patients will relapse with metastatic disease and molecular tests to predict relapse are needed. TP63 has been proposed as a prognostic biomarker in bladder cancer, but reports associating it with clinical outcomes are conflicting. Since TP63 is exp...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953644/ https://www.ncbi.nlm.nih.gov/pubmed/31927310 http://dx.doi.org/10.1016/j.ebiom.2019.11.022 |